메뉴 건너뛰기




Volumn 171, Issue 24, 2014, Pages 5555-5572

Endothelin@25 - New agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12

Author keywords

[No Author keywords available]

Indexed keywords

AMBRISENTAN; BOSENTAN; CAPTOPRIL; CHYMASE; DAGLUTRIL; DOCETAXEL; ECE 1 PROTEIN; ECE 2 PROTEIN; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN DERIVATIVE; ET LIKE DOMAIN PEPTIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KELL PROTEIN; MACITENTAN; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHORAMIDON; SITAXSENTAN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; THIORPHAN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ASPARTIC PROTEINASE; BENZAZEPINE DERIVATIVE; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN-CONVERTING ENZYME; METALLOPROTEINASE; PEPTIDE FRAGMENT; PHENYLPROPIONIC ACID DERIVATIVE; PYRIDAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SULFONAMIDE; VASODILATOR AGENT;

EID: 84918774657     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12874     Document Type: Article
Times cited : (56)

References (170)
  • 1
    • 0028069915 scopus 로고
    • Endothelin-A receptors mediate contraction in human cerebral, meningeal and temporal arteries
    • Adner M, Jansen I, Edvinsson L, (1994). Endothelin-A receptors mediate contraction in human cerebral, meningeal and temporal arteries. J Auton Nerv Syst 49 (Suppl.): S117-S121.
    • (1994) J Auton Nerv Syst , vol.49 , pp. S117-S121
    • Adner, M.1    Jansen, I.2    Edvinsson, L.3
  • 5
    • 84872875918 scopus 로고    scopus 로고
    • Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor
    • Allard B, Wijkhuisen A, Borrull A, Deshayes F, Priam F, Lamourette P, et al. (2013). Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor. MAbs 5: 56-69.
    • (2013) MAbs , vol.5 , pp. 56-69
    • Allard, B.1    Wijkhuisen, A.2    Borrull, A.3    Deshayes, F.4    Priam, F.5    Lamourette, P.6
  • 6
    • 0025605345 scopus 로고
    • Cloning and expression of a cDNA encoding an endothelin receptor
    • Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S, (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732.
    • (1990) Nature , vol.348 , pp. 730-732
    • Arai, H.1    Hori, S.2    Aramori, I.3    Ohkubo, H.4    Nakanishi, S.5
  • 7
    • 33747603873 scopus 로고    scopus 로고
    • Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt
    • Bagnall AJ, Kelland NF, Gulliver-Sloan F, Davenport AP, Gray GA, Yanagisawa M, et al. (2006). Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension 48: 286-293.
    • (2006) Hypertension , vol.48 , pp. 286-293
    • Bagnall, A.J.1    Kelland, N.F.2    Gulliver-Sloan, F.3    Davenport, A.P.4    Gray, G.A.5    Yanagisawa, M.6
  • 8
    • 79954456308 scopus 로고    scopus 로고
    • Role of the endothelin axis and its antagonists in the treatment of cancer
    • Bagnato A, Loizidou M, Pflug BR, Curwen J, Growcott J, (2011). Role of the endothelin axis and its antagonists in the treatment of cancer. Br J Pharmacol 163: 220-233.
    • (2011) Br J Pharmacol , vol.163 , pp. 220-233
    • Bagnato, A.1    Loizidou, M.2    Pflug, B.R.3    Curwen, J.4    Growcott, J.5
  • 10
    • 48849094089 scopus 로고    scopus 로고
    • Endothelin: 20 years from discovery to therapy
    • Barton M, Yanagisawa M, (2008). Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol 86: 485-498.
    • (2008) Can J Physiol Pharmacol , vol.86 , pp. 485-498
    • Barton, M.1    Yanagisawa, M.2
  • 11
    • 0028609612 scopus 로고
    • Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons
    • Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, et al. (1994). Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79: 1277-1285.
    • (1994) Cell , vol.79 , pp. 1277-1285
    • Baynash, A.G.1    Hosoda, K.2    Giaid, A.3    Richardson, J.A.4    Emoto, N.5    Hammer, R.E.6
  • 12
    • 84866307803 scopus 로고    scopus 로고
    • The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N-p ropylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist
    • Bolli MH, Boss C, Binkert C, Buchmann S, Bur D, Hess P, et al. (2012). The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N-p ropylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist. J Med Chem 55: 7849-7861.
    • (2012) J Med Chem , vol.55 , pp. 7849-7861
    • Bolli, M.H.1    Boss, C.2    Binkert, C.3    Buchmann, S.4    Bur, D.5    Hess, P.6
  • 13
    • 84874564133 scopus 로고    scopus 로고
    • Endothelin-2-mediated protection of mutant photoreceptors in inherited photoreceptor degeneration
    • Bramall AN, Szego MJ, Pacione LR, Chang I, Diez E, D'Orleans-Juste P, et al. (2013). Endothelin-2-mediated protection of mutant photoreceptors in inherited photoreceptor degeneration. PLoS ONE 8: e58023.
    • (2013) PLoS ONE , vol.8 , pp. e58023
    • Bramall, A.N.1    Szego, M.J.2    Pacione, L.R.3    Chang, I.4    Diez, E.5    D'Orleans-Juste, P.6
  • 14
    • 84867652327 scopus 로고    scopus 로고
    • Constitutive overexpression of Norrin activates Wnt/beta-catenin and endothelin-2 signaling to protect photoreceptors from light damage
    • Braunger BM, Ohlmann A, Koch M, Tanimoto N, Volz C, Yang Y, et al. (2013). Constitutive overexpression of Norrin activates Wnt/beta-catenin and endothelin-2 signaling to protect photoreceptors from light damage. Neurobiol Dis 50: 1-12.
    • (2013) Neurobiol Dis , vol.50 , pp. 1-12
    • Braunger, B.M.1    Ohlmann, A.2    Koch, M.3    Tanimoto, N.4    Volz, C.5    Yang, Y.6
  • 16
    • 84895512179 scopus 로고    scopus 로고
    • Endothelin receptor type B agonist, IRL-1620, prevents beta amyloid (Abeta) induced oxidative stress and cognitive impairment in normal and diabetic rats
    • Briyal S, Shepard C, Gulati A, (2014). Endothelin receptor type B agonist, IRL-1620, prevents beta amyloid (Abeta) induced oxidative stress and cognitive impairment in normal and diabetic rats. Pharmacol Biochem Behav 120C: 65-72.
    • (2014) Pharmacol Biochem Behav , vol.120 C , pp. 65-72
    • Briyal, S.1    Shepard, C.2    Gulati, A.3
  • 17
    • 84857627857 scopus 로고    scopus 로고
    • Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist
    • Bruderer S, Aanismaa P, Homery MC, Hausler S, Landskroner K, Sidharta PN, et al. (2012a). Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist. AAPS J 14: 68-78.
    • (2012) AAPS J , vol.14 , pp. 68-78
    • Bruderer, S.1    Aanismaa, P.2    Homery, M.C.3    Hausler, S.4    Landskroner, K.5    Sidharta, P.N.6
  • 18
    • 84865010567 scopus 로고    scopus 로고
    • Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans
    • Bruderer S, Hopfgartner G, Seiberling M, Wank J, Sidharta PN, Treiber A, et al. (2012b). Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans. Xenobiotica 42: 901-910.
    • (2012) Xenobiotica , vol.42 , pp. 901-910
    • Bruderer, S.1    Hopfgartner, G.2    Seiberling, M.3    Wank, J.4    Sidharta, P.N.5    Treiber, A.6
  • 19
    • 84879477934 scopus 로고    scopus 로고
    • Pharmacokinetics of macitentan in Caucasian and Japanese subjects: The influence of ethnicity and sex
    • Bruderer S, Marjason J, Sidharta PN, Dingemanse J, (2013). Pharmacokinetics of macitentan in Caucasian and Japanese subjects: the influence of ethnicity and sex. Pharmacology 91: 331-338.
    • (2013) Pharmacology , vol.91 , pp. 331-338
    • Bruderer, S.1    Marjason, J.2    Sidharta, P.N.3    Dingemanse, J.4
  • 20
    • 84896867400 scopus 로고    scopus 로고
    • Beta-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury
    • Buelli S, Rosano L, Gagliardini E, Corna D, Longaretti L, Pezzotta A, et al. (2014). Beta-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury. J Am Soc Nephrol 25: 523-533.
    • (2014) J Am Soc Nephrol , vol.25 , pp. 523-533
    • Buelli, S.1    Rosano, L.2    Gagliardini, E.3    Corna, D.4    Longaretti, L.5    Pezzotta, A.6
  • 21
    • 0025661934 scopus 로고
    • Lack of biological activity of preproendothelin [110-130] in several endothelin assays
    • Cade C, Lumma WC Jr, Mohan R, Rubanyi GM, Parker-Botelho LH, (1990). Lack of biological activity of preproendothelin [110-130] in several endothelin assays. Life Sci 47: 2097-2103.
    • (1990) Life Sci , vol.47 , pp. 2097-2103
    • Cade, C.1    Lumma, W.C.2    Mohan, R.3    Rubanyi, G.M.4    Parker-Botelho, L.H.5
  • 22
    • 84878584063 scopus 로고    scopus 로고
    • Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice
    • Chang I, Bramall AN, Baynash AG, Rattner A, Rakheja D, Post M, et al. (2013). Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. J Clin Invest 123: 2643-2653.
    • (2013) J Clin Invest , vol.123 , pp. 2643-2653
    • Chang, I.1    Bramall, A.N.2    Baynash, A.G.3    Rattner, A.4    Rakheja, D.5    Post, M.6
  • 23
    • 84894528689 scopus 로고    scopus 로고
    • Beta-arrestin 1 is required for endothelin-1-induced NF-kappaB activation in ovarian cancer cells
    • Cianfrocca R, Tocci P, Semprucci E, Spinella F, Di Castro V, Bagnato A, et al. (2014). Beta-arrestin 1 is required for endothelin-1-induced NF-kappaB activation in ovarian cancer cells. Life Sci. doi: 10.1016/j.lfs.2014.01.078
    • (2014) Life Sci
    • Cianfrocca, R.1    Tocci, P.2    Semprucci, E.3    Spinella, F.4    Di Castro, V.5    Bagnato, A.6
  • 25
    • 0028824396 scopus 로고
    • Are there different ETB receptors mediating constriction and relaxation?
    • Clozel M, Gray GA, (1995). Are there different ETB receptors mediating constriction and relaxation? J Cardiovasc Pharmacol 26 (Suppl. 3): S262-S264.
    • (1995) J Cardiovasc Pharmacol , vol.26 , pp. S262-S264
    • Clozel, M.1    Gray, G.A.2
  • 26
    • 84886796389 scopus 로고    scopus 로고
    • Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries
    • Compeer MG, Janssen GM, De Mey JG, (2013). Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries. Br J Pharmacol 170: 1199-1209.
    • (2013) Br J Pharmacol , vol.170 , pp. 1199-1209
    • Compeer, M.G.1    Janssen, G.M.2    De Mey, J.G.3
  • 27
    • 0036266042 scopus 로고    scopus 로고
    • International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature
    • Davenport AP, (2002). International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 54: 219-226.
    • (2002) Pharmacol Rev , vol.54 , pp. 219-226
    • Davenport, A.P.1
  • 29
    • 0025181868 scopus 로고
    • A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: Comparison of levels in patients with essential hypertension and normotensive control subjects
    • Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, et al. (1990). A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci (Lond) 78: 261-264.
    • (1990) Clin Sci (Lond) , vol.78 , pp. 261-264
    • Davenport, A.P.1    Ashby, M.J.2    Easton, P.3    Ella, S.4    Bedford, J.5    Dickerson, C.6
  • 30
    • 84878371294 scopus 로고    scopus 로고
    • International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: Recommendations for new pairings with cognate ligands
    • Davenport AP, Alexander SP, Sharman JL, Pawson AJ, Benson HE, Monaghan AE, et al. (2013). International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol Rev 65: 967-986.
    • (2013) Pharmacol Rev , vol.65 , pp. 967-986
    • Davenport, A.P.1    Alexander, S.P.2    Sharman, J.L.3    Pawson, A.J.4    Benson, H.E.5    Monaghan, A.E.6
  • 31
    • 0028171845 scopus 로고
    • Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme
    • De Lombaert S, Ghai RD, Jeng AY, Trapani AJ, Webb RL, (1994). Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem Biophys Res Commun 204: 407-412.
    • (1994) Biochem Biophys Res Commun , vol.204 , pp. 407-412
    • De Lombaert, S.1    Ghai, R.D.2    Jeng, A.Y.3    Trapani, A.J.4    Webb, R.L.5
  • 32
    • 84855498432 scopus 로고    scopus 로고
    • Endothelin antagonism in patients with nondiabetic chronic kidney disease
    • Dhaun N, Goddard J, Webb DJ, (2011). Endothelin antagonism in patients with nondiabetic chronic kidney disease. Contrib Nephrol 172: 243-254.
    • (2011) Contrib Nephrol , vol.172 , pp. 243-254
    • Dhaun, N.1    Goddard, J.2    Webb, D.J.3
  • 33
    • 84866979287 scopus 로고    scopus 로고
    • Endothelin-1 and the kidney-beyond BP
    • Dhaun N, Webb DJ, Kluth DC, (2012). Endothelin-1 and the kidney-beyond BP. Br J Pharmacol 167: 720-731.
    • (2012) Br J Pharmacol , vol.167 , pp. 720-731
    • Dhaun, N.1    Webb, D.J.2    Kluth, D.C.3
  • 34
    • 3142576948 scopus 로고    scopus 로고
    • Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failure
    • Dickstein K, De Voogd HJ, Miric MP, Willenbrock R, Mitrovic V, Pacher R, et al. (2004). Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failure. Am J Cardiol 94: 237-239.
    • (2004) Am J Cardiol , vol.94 , pp. 237-239
    • Dickstein, K.1    De Voogd, H.J.2    Miric, M.P.3    Willenbrock, R.4    Mitrovic, V.5    Pacher, R.6
  • 36
    • 84871383146 scopus 로고    scopus 로고
    • Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan
    • Don GW, Joseph F, Celermajer DS, Corte TJ, (2012). Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan. Intern Med J 42: 1351-1354.
    • (2012) Intern Med J , vol.42 , pp. 1351-1354
    • Don, G.W.1    Joseph, F.2    Celermajer, D.S.3    Corte, T.J.4
  • 38
    • 84871585276 scopus 로고    scopus 로고
    • The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth
    • Drawnel FM, Archer CR, Roderick HL, (2013). The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. Br J Pharmacol 168: 296-317.
    • (2013) Br J Pharmacol , vol.168 , pp. 296-317
    • Drawnel, F.M.1    Archer, C.R.2    Roderick, H.L.3
  • 39
    • 0035816707 scopus 로고    scopus 로고
    • Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme
    • Eckman EA, Reed DK, Eckman CB, (2001). Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme. J Biol Chem 276: 24540-24548.
    • (2001) J Biol Chem , vol.276 , pp. 24540-24548
    • Eckman, E.A.1    Reed, D.K.2    Eckman, C.B.3
  • 40
    • 0037462769 scopus 로고    scopus 로고
    • Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme
    • Eckman EA, Watson M, Marlow L, Sambamurti K, Eckman CB, (2003). Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem 278: 2081-2084.
    • (2003) J Biol Chem , vol.278 , pp. 2081-2084
    • Eckman, E.A.1    Watson, M.2    Marlow, L.3    Sambamurti, K.4    Eckman, C.B.5
  • 41
    • 33750047859 scopus 로고    scopus 로고
    • Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme
    • Eckman EA, Adams SK, Troendle FJ, Stodola BA, Kahn MA, Fauq AH, et al. (2006). Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. J Biol Chem 281: 30471-30478.
    • (2006) J Biol Chem , vol.281 , pp. 30471-30478
    • Eckman, E.A.1    Adams, S.K.2    Troendle, F.J.3    Stodola, B.A.4    Kahn, M.A.5    Fauq, A.H.6
  • 42
    • 0029017876 scopus 로고
    • Endothelin-converting enzyme-2 is a membrane-bound,phosphoramidon-sensitive metalloprotease with acidic pH optimum
    • Emoto N, Yanagisawa M, (1995). Endothelin-converting enzyme-2 is a membrane-bound,phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270: 15262-15268.
    • (1995) J Biol Chem , vol.270 , pp. 15262-15268
    • Emoto, N.1    Yanagisawa, M.2
  • 43
    • 21744460362 scopus 로고    scopus 로고
    • Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo
    • Fecteau MH, Honore JC, Plante M, Labonte J, Rae GA, D'Orleans-Juste P, (2005). Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo. Hypertension 46: 87-92.
    • (2005) Hypertension , vol.46 , pp. 87-92
    • Fecteau, M.H.1    Honore, J.C.2    Plante, M.3    Labonte, J.4    Rae, G.A.5    D'Orleans-Juste, P.6
  • 44
    • 0031799003 scopus 로고    scopus 로고
    • Endothelin B receptors on human endothelial and smooth-muscle cells show equivalent binding pharmacology
    • Flynn MA, Haleen SJ, Welch KM, Cheng XM, Reynolds EE, (1998). Endothelin B receptors on human endothelial and smooth-muscle cells show equivalent binding pharmacology. J Cardiovasc Pharmacol 32: 106-116.
    • (1998) J Cardiovasc Pharmacol , vol.32 , pp. 106-116
    • Flynn, M.A.1    Haleen, S.J.2    Welch, K.M.3    Cheng, X.M.4    Reynolds, E.E.5
  • 46
    • 84867562420 scopus 로고    scopus 로고
    • Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells
    • Gatfield J, Mueller Grandjean C, Sasse T, Clozel M, Nayler O, (2012). Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells. PLoS ONE 7: e47662.
    • (2012) PLoS ONE , vol.7 , pp. e47662
    • Gatfield, J.1    Mueller Grandjean, C.2    Sasse, T.3    Clozel, M.4    Nayler, O.5
  • 47
    • 0025975489 scopus 로고
    • Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain
    • Giaid A, Gibson SJ, Herrero MT, Gentleman S, Legon S, Yanagisawa M, et al. (1991). Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry 95: 303-314.
    • (1991) Histochemistry , vol.95 , pp. 303-314
    • Giaid, A.1    Gibson, S.J.2    Herrero, M.T.3    Gentleman, S.4    Legon, S.5    Yanagisawa, M.6
  • 48
    • 11144305358 scopus 로고    scopus 로고
    • Endothelin-1-induced vasodilatation in rat Breast tumor is mediated through endothelin-B receptors
    • Gulati A, Rai A, (2004). Endothelin-1-induced vasodilatation in rat Breast tumor is mediated through endothelin-B receptors. J Cardiovasc Pharmacol 44: S483-S486.
    • (2004) J Cardiovasc Pharmacol , vol.44 , pp. S483-S486
    • Gulati, A.1    Rai, A.2
  • 49
    • 84858729714 scopus 로고    scopus 로고
    • IRL-1620, an endothelin-B receptor agonist, enhanced radiation induced reduction in tumor volume in Dalton's Lymphoma Ascites tumor model
    • Gulati A, Sunila ES, Kuttan G, (2012). IRL-1620, an endothelin-B receptor agonist, enhanced radiation induced reduction in tumor volume in Dalton's Lymphoma Ascites tumor model. Arzneimittelforschung 62: 14-17.
    • (2012) Arzneimittelforschung , vol.62 , pp. 14-17
    • Gulati, A.1    Sunila, E.S.2    Kuttan, G.3
  • 50
    • 0032910612 scopus 로고    scopus 로고
    • Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure
    • Hand MF, Haynes WG, Webb DJ, (1999). Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure. Kidney Int 55: 613-620.
    • (1999) Kidney Int , vol.55 , pp. 613-620
    • Hand, M.F.1    Haynes, W.G.2    Webb, D.J.3
  • 51
    • 0028827686 scopus 로고
    • Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas
    • Harland SP, Kuc RE, Pickard JD, Davenport AP, (1995). Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas. J Cardiovasc Pharmacol 26 (Suppl. 3): S408-S411.
    • (1995) J Cardiovasc Pharmacol , vol.26 , pp. S408-S411
    • Harland, S.P.1    Kuc, R.E.2    Pickard, J.D.3    Davenport, A.P.4
  • 52
    • 0031752311 scopus 로고    scopus 로고
    • Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707
    • Harland SP, Kuc RE, Pickard JD, Davenport AP, (1998). Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery 43: 890-898.
    • (1998) Neurosurgery , vol.43 , pp. 890-898
    • Harland, S.P.1    Kuc, R.E.2    Pickard, J.D.3    Davenport, A.P.4
  • 53
    • 0027983753 scopus 로고
    • Contribution of endogenous generation of endothelin-1 to basal vascular tone
    • Haynes WG, Webb DJ, (1994). Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344: 852-854.
    • (1994) Lancet , vol.344 , pp. 852-854
    • Haynes, W.G.1    Webb, D.J.2
  • 54
    • 79960286159 scopus 로고    scopus 로고
    • Dual endothelin-converting enzyme/neutral endopeptidase blockade in rats with D-galactosamine-induced liver failure
    • Hocher B, Heiden S, von Websky K, Rahnenfuhre J, Kalk P, Pfab T, (2011). Dual endothelin-converting enzyme/neutral endopeptidase blockade in rats with D-galactosamine-induced liver failure. Eur J Med Res 16: 275-279.
    • (2011) Eur J Med Res , vol.16 , pp. 275-279
    • Hocher, B.1    Heiden, S.2    Von Websky, K.3    Rahnenfuhre, J.4    Kalk, P.5    Pfab, T.6
  • 55
    • 0028639196 scopus 로고
    • Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
    • Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A, et al. (1994). Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79: 1267-1276.
    • (1994) Cell , vol.79 , pp. 1267-1276
    • Hosoda, K.1    Hammer, R.E.2    Richardson, J.A.3    Baynash, A.G.4    Cheung, J.C.5    Giaid, A.6
  • 56
    • 0026480318 scopus 로고
    • Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue
    • Howard PG, Plumpton C, Davenport AP, (1992). Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens 10: 1379-1386.
    • (1992) J Hypertens , vol.10 , pp. 1379-1386
    • Howard, P.G.1    Plumpton, C.2    Davenport, A.P.3
  • 57
    • 84871751539 scopus 로고    scopus 로고
    • Nitric oxide and the A and B of endothelin of sodium homeostasis
    • Hyndman KA, Pollock JS, (2013). Nitric oxide and the A and B of endothelin of sodium homeostasis. Curr Opin Nephrol Hypertens 22: 26-31.
    • (2013) Curr Opin Nephrol Hypertens , vol.22 , pp. 26-31
    • Hyndman, K.A.1    Pollock, J.S.2
  • 58
    • 57349133022 scopus 로고    scopus 로고
    • Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist
    • Iglarz M, Binkert C, Morrison K, Fischli W, Gatfield J, Treiber A, et al. (2008). Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist. J Pharmacol Exp Ther 327: 736-745.
    • (2008) J Pharmacol Exp Ther , vol.327 , pp. 736-745
    • Iglarz, M.1    Binkert, C.2    Morrison, K.3    Fischli, W.4    Gatfield, J.5    Treiber, A.6
  • 61
    • 0013543367 scopus 로고
    • The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
    • Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, et al. (1989). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86: 2863-2867.
    • (1989) Proc Natl Acad Sci U S A , vol.86 , pp. 2863-2867
    • Inoue, A.1    Yanagisawa, M.2    Kimura, S.3    Kasuya, Y.4    Miyauchi, T.5    Goto, K.6
  • 62
    • 0028237258 scopus 로고
    • Biochemical and pharmacological profile of a potent and selective endothelinB-receptor antagonist, BQ-788
    • Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, et al. (1994). Biochemical and pharmacological profile of a potent and selective endothelinB-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A 91: 4892-4896.
    • (1994) Proc Natl Acad Sci U S A , vol.91 , pp. 4892-4896
    • Ishikawa, K.1    Ihara, M.2    Noguchi, K.3    Mase, T.4    Mino, N.5    Saeki, T.6
  • 63
    • 84887057897 scopus 로고    scopus 로고
    • Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-beta peptide(1-40) in mouse brain
    • Ito S, Matsumiya K, Ohtsuki S, Kamiie J, Terasaki T, (2013). Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-beta peptide(1-40) in mouse brain. J Cereb Blood Flow Metab 33: 1770-1777.
    • (2013) J Cereb Blood Flow Metab , vol.33 , pp. 1770-1777
    • Ito, S.1    Matsumiya, K.2    Ohtsuki, S.3    Kamiie, J.4    Terasaki, T.5
  • 64
    • 0036099334 scopus 로고    scopus 로고
    • Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications
    • Jeng AY, Mulder P, Kwan AL, Battistini B, (2002). Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications. Can J Physiol Pharmacol 80: 440-449.
    • (2002) Can J Physiol Pharmacol , vol.80 , pp. 440-449
    • Jeng, A.Y.1    Mulder, P.2    Kwan, A.L.3    Battistini, B.4
  • 65
    • 77249163226 scopus 로고    scopus 로고
    • Positron emission tomography of [18F]-big endothelin-1 reveals renal excretion but tissue-specific conversion to [18F]-endothelin-1 in lung and liver
    • Johnström P, Fryer TD, Richards HK, Maguire JJ, Clark JC, Pickard JD, et al. (2010). Positron emission tomography of [18F]-big endothelin-1 reveals renal excretion but tissue-specific conversion to [18F]-endothelin-1 in lung and liver. Br J Pharmacol 159: 812-819.
    • (2010) Br J Pharmacol , vol.159 , pp. 812-819
    • Johnström, P.1    Fryer, T.D.2    Richards, H.K.3    Maguire, J.J.4    Clark, J.C.5    Pickard, J.D.6
  • 66
    • 79953200072 scopus 로고    scopus 로고
    • Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner
    • Kalk P, Sharkovska Y, Kashina E, von Websky K, Relle K, Pfab T, et al. (2011). Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner. Hypertension 57: 755-763.
    • (2011) Hypertension , vol.57 , pp. 755-763
    • Kalk, P.1    Sharkovska, Y.2    Kashina, E.3    Von Websky, K.4    Relle, K.5    Pfab, T.6
  • 67
    • 0030044458 scopus 로고    scopus 로고
    • Localization of endothelin peptides in human kidney
    • Karet FE, Davenport AP, (1996). Localization of endothelin peptides in human kidney. Kidney Int 49: 382-387.
    • (1996) Kidney Int , vol.49 , pp. 382-387
    • Karet, F.E.1    Davenport, A.P.2
  • 68
    • 79952278486 scopus 로고    scopus 로고
    • Endothelial cell-specific ETB receptor knockout: Autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1
    • Kelland NF, Kuc RE, McLean DL, Azfer A, Bagnall AJ, Gray GA, et al. (2010). Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol 88: 644-651.
    • (2010) Can J Physiol Pharmacol , vol.88 , pp. 644-651
    • Kelland, N.F.1    Kuc, R.E.2    McLean, D.L.3    Azfer, A.4    Bagnall, A.J.5    Gray, G.A.6
  • 69
    • 33744942636 scopus 로고    scopus 로고
    • Clinical trials of endothelin antagonists in heart failure: A question of dose?
    • Kelland NF, Webb DJ, (2006). Clinical trials of endothelin antagonists in heart failure: a question of dose? Exp Biol Med (Maywood) 231: 696-699.
    • (2006) Exp Biol Med (Maywood) , vol.231 , pp. 696-699
    • Kelland, N.F.1    Webb, D.J.2
  • 70
    • 0025967080 scopus 로고
    • Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor
    • Kiowski W, Luscher TF, Linder L, Buhler FR, (1991). Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 83: 469-475.
    • (1991) Circulation , vol.83 , pp. 469-475
    • Kiowski, W.1    Luscher, T.F.2    Linder, L.3    Buhler, F.R.4
  • 71
    • 40949132561 scopus 로고    scopus 로고
    • The endothelin system as a therapeutic target in cardiovascular disease: Great expectations or bleak house?
    • Kirkby NS, Hadoke PW, Bagnall AJ, Webb DJ, (2008). The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? J Pharmacol 153: 1105-1119.
    • (2008) J Pharmacol , vol.153 , pp. 1105-1119
    • Kirkby, N.S.1    Hadoke, P.W.2    Bagnall, A.J.3    Webb, D.J.4
  • 73
    • 84867580770 scopus 로고    scopus 로고
    • Why two endothelins and two receptors for ovulation and luteal regulation?
    • Ko C, Meidan R, Bridges PJ, (2012). Why two endothelins and two receptors for ovulation and luteal regulation? Life Sci 91: 501-506.
    • (2012) Life Sci , vol.91 , pp. 501-506
    • Ko, C.1    Meidan, R.2    Bridges, P.J.3
  • 75
    • 78751672175 scopus 로고    scopus 로고
    • Regulation of blood pressure and salt homeostasis by endothelin
    • Kohan DE, Rossi NF, Inscho EW, Pollock DM, (2011b). Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev 91: 1-77.
    • (2011) Physiol Rev , vol.91 , pp. 1-77
    • Kohan, D.E.1    Rossi, N.F.2    Inscho, E.W.3    Pollock, D.M.4
  • 76
    • 84867578602 scopus 로고    scopus 로고
    • Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve?
    • Kohan DE, Cleland JG, Rubin LJ, Theodorescu D, Barton M, (2012). Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve? Life Sci 91: 528-539.
    • (2012) Life Sci , vol.91 , pp. 528-539
    • Kohan, D.E.1    Cleland, J.G.2    Rubin, L.J.3    Theodorescu, D.4    Barton, M.5
  • 77
    • 84990943531 scopus 로고    scopus 로고
    • Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension
    • Kuc RE, Carlebur M, Maguire JJ, Yang P, Long L, Toshner M, et al. (2014). Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension. Life Sci. doi: 10.1016/j.lfs.2014.02.020
    • (2014) Life Sci
    • Kuc, R.E.1    Carlebur, M.2    Maguire, J.J.3    Yang, P.4    Long, L.5    Toshner, M.6
  • 78
    • 0028360062 scopus 로고
    • Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
    • Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, et al. (1994). Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703-710.
    • (1994) Nature , vol.368 , pp. 703-710
    • Kurihara, Y.1    Kurihara, H.2    Suzuki, H.3    Kodama, T.4    Maemura, K.5    Nagai, R.6
  • 79
    • 0041858484 scopus 로고    scopus 로고
    • Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries
    • Kutzler MA, Molnar J, Schlafer DH, Kuc RE, Davenport AP, Nathanielsz PW, (2003). Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries. Placenta 24: 392-402.
    • (2003) Placenta , vol.24 , pp. 392-402
    • Kutzler, M.A.1    Molnar, J.2    Schlafer, D.H.3    Kuc, R.E.4    Davenport, A.P.5    Nathanielsz, P.W.6
  • 80
    • 0033566651 scopus 로고    scopus 로고
    • Proteolytic processing of big endothelin-3 by the kell blood group protein
    • Lee S, Lin M, Mele A, Cao Y, Farmar J, Russo D, et al. (1999). Proteolytic processing of big endothelin-3 by the kell blood group protein. Blood 94: 1440-1450.
    • (1999) Blood , vol.94 , pp. 1440-1450
    • Lee, S.1    Lin, M.2    Mele, A.3    Cao, Y.4    Farmar, J.5    Russo, D.6
  • 81
    • 84918772685 scopus 로고    scopus 로고
    • IRL-1620 increases the efficacy of radiation treatment in mice bearing lymphoma cell induced tumors
    • Lenaz L, Gulati A, Sunila E, (2006). IRL-1620 increases the efficacy of radiation treatment in mice bearing lymphoma cell induced tumors. Blood 108: 269B.
    • (2006) Blood , vol.108 , pp. 269B
    • Lenaz, L.1    Gulati, A.2    Sunila, E.3
  • 82
    • 84882263300 scopus 로고    scopus 로고
    • Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats
    • Leonard MG, Gulati A, (2013). Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats. Brain Res 1528: 28-41.
    • (2013) Brain Res , vol.1528 , pp. 28-41
    • Leonard, M.G.1    Gulati, A.2
  • 83
    • 80055056846 scopus 로고    scopus 로고
    • Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats
    • Leonard MG, Briyal S, Gulati A, (2011). Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats. Brain Res 1420: 48-58.
    • (2011) Brain Res , vol.1420 , pp. 48-58
    • Leonard, M.G.1    Briyal, S.2    Gulati, A.3
  • 84
    • 84862017602 scopus 로고    scopus 로고
    • Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats
    • Leonard MG, Briyal S, Gulati A, (2012). Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats. Brain Res 1464: 14-23.
    • (2012) Brain Res , vol.1464 , pp. 14-23
    • Leonard, M.G.1    Briyal, S.2    Gulati, A.3
  • 85
    • 84871603109 scopus 로고    scopus 로고
    • Endothelin-2, the forgotten isoform: Emerging role in the cardiovascular system, ovarian development, immunology and cancer
    • Ling L, Maguire JJ, Davenport AP, (2013). Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer. Br J Pharmacol 168: 283-295.
    • (2013) Br J Pharmacol , vol.168 , pp. 283-295
    • Ling, L.1    Maguire, J.J.2    Davenport, A.P.3
  • 86
    • 84875513420 scopus 로고    scopus 로고
    • Endothelin receptor antagonists for pulmonary arterial hypertension
    • CD004434.
    • Liu C, Chen J, Gao Y, Deng B, Liu K, (2013). Endothelin receptor antagonists for pulmonary arterial hypertension. Cochrane Database Syst Rev (2): CD004434.
    • (2013) Cochrane Database Syst Rev , Issue.2
    • Liu, C.1    Chen, J.2    Gao, Y.3    Deng, B.4    Liu, K.5
  • 87
    • 0035846451 scopus 로고    scopus 로고
    • Human endothelin converting enzyme-2 (ECE2): Characterization of mRNA species and chromosomal localization
    • Lorenzo MN, Khan RY, Wang Y, Tai SC, Chan GC, Cheung AH, et al. (2001). Human endothelin converting enzyme-2 (ECE2): characterization of mRNA species and chromosomal localization. Biochim Biophys Acta 1522: 46-52.
    • (2001) Biochim Biophys Acta , vol.1522 , pp. 46-52
    • Lorenzo, M.N.1    Khan, R.Y.2    Wang, Y.3    Tai, S.C.4    Chan, G.C.5    Cheung, A.H.6
  • 90
    • 84896703861 scopus 로고    scopus 로고
    • Minireview: More than just a hammer: Ligand 'bias' and pharmaceutical discovery
    • Luttrell LM, (2014). Minireview: more than just a hammer: ligand 'bias' and pharmaceutical discovery. Mol Endocrinol 28: 281-294.
    • (2014) Mol Endocrinol , vol.28 , pp. 281-294
    • Luttrell, L.M.1
  • 91
    • 0031671310 scopus 로고    scopus 로고
    • Increased response to big endothelin-1 in atherosclerotic human coronary artery: Functional evidence for up-regulation of endothelin-converting enzyme activity in disease
    • Maguire JJ, Davenport AP, (1998). Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease. Br J Pharmacol 125: 238-240.
    • (1998) Br J Pharmacol , vol.125 , pp. 238-240
    • Maguire, J.J.1    Davenport, A.P.2
  • 92
    • 11144314960 scopus 로고    scopus 로고
    • Alternative pathway to endothelin-converting enzyme for the synthesis of endothelin in human blood vessels
    • Maguire JJ, Davenport AP, (2004). Alternative pathway to endothelin-converting enzyme for the synthesis of endothelin in human blood vessels. J Cardiovasc Pharmacol 44 (Suppl. 1): S27-S29.
    • (2004) J Cardiovasc Pharmacol , vol.44 , pp. S27-S29
    • Maguire, J.J.1    Davenport, A.P.2
  • 93
    • 0031451616 scopus 로고    scopus 로고
    • Endothelin converting enzyme (ECE). Activity in human vascular smooth muscle
    • Maguire JJ, Johnson CM, Mockridge JW, Davenport AP, (1997). Endothelin converting enzyme (ECE). Activity in human vascular smooth muscle. Br J Pharmacol 122: 1647-1654.
    • (1997) Br J Pharmacol , vol.122 , pp. 1647-1654
    • Maguire, J.J.1    Johnson, C.M.2    Mockridge, J.W.3    Davenport, A.P.4
  • 94
    • 0035200903 scopus 로고    scopus 로고
    • Vasoconstrictor activity of novel endothelin peptide, ET-1(1-31), in human mammary and coronary arteries in vitro
    • Maguire JJ, Kuc RE, Davenport AP, (2001). Vasoconstrictor activity of novel endothelin peptide, ET-1(1-31), in human mammary and coronary arteries in vitro. Br J Pharmacol 134: 1360-1366.
    • (2001) Br J Pharmacol , vol.134 , pp. 1360-1366
    • Maguire, J.J.1    Kuc, R.E.2    Davenport, A.P.3
  • 95
    • 84867581538 scopus 로고    scopus 로고
    • Comparison of human ETA and ETB receptor signalling via G-protein and beta-arrestin pathways
    • Maguire JJ, Kuc RE, Pell VR, Green A, Brown M, Kumar S, et al. (2012). Comparison of human ETA and ETB receptor signalling via G-protein and beta-arrestin pathways. Life Sci 91: 544-549.
    • (2012) Life Sci , vol.91 , pp. 544-549
    • Maguire, J.J.1    Kuc, R.E.2    Pell, V.R.3    Green, A.4    Brown, M.5    Kumar, S.6
  • 97
    • 0003315531 scopus 로고    scopus 로고
    • Pharmacology of the active metabolite of SLV 306 - A mixed inhibitor of NEP and ECE
    • Meil J, Wurl M, Thormahlen D, Rose H, (1998). Pharmacology of the active metabolite of SLV 306-a mixed inhibitor of NEP and ECE. Naunyn Schmiedebergs Arch Pharmacol 358 (Suppl. 1): R513.
    • (1998) Naunyn Schmiedebergs Arch Pharmacol , vol.358 , pp. R513
    • Meil, J.1    Wurl, M.2    Thormahlen, D.3    Rose, H.4
  • 98
    • 84878715626 scopus 로고    scopus 로고
    • GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin
    • Meyer RC, Giddens MM, Schaefer SA, Hall RA, (2013). GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proc Natl Acad Sci U S A 110: 9529-9534.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , pp. 9529-9534
    • Meyer, R.C.1    Giddens, M.M.2    Schaefer, S.A.3    Hall, R.A.4
  • 99
    • 8244248458 scopus 로고    scopus 로고
    • Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse
    • Mizuguchi T, Nishiyama M, Moroi K, Tanaka H, Saito T, Masuda Y, et al. (1997). Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Br J Pharmacol 120: 1427-1430.
    • (1997) Br J Pharmacol , vol.120 , pp. 1427-1430
    • Mizuguchi, T.1    Nishiyama, M.2    Moroi, K.3    Tanaka, H.4    Saito, T.5    Masuda, Y.6
  • 100
    • 0026615753 scopus 로고
    • Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart
    • Molenaar P, Kuc RE, Davenport AP, (1992). Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Br J Pharmacol 107: 637-639.
    • (1992) Br J Pharmacol , vol.107 , pp. 637-639
    • Molenaar, P.1    Kuc, R.E.2    Davenport, A.P.3
  • 101
    • 0027538163 scopus 로고
    • Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium
    • Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, et al. (1993). Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72: 526-538.
    • (1993) Circ Res , vol.72 , pp. 526-538
    • Molenaar, P.1    O'Reilly, G.2    Sharkey, A.3    Kuc, R.E.4    Harding, D.P.5    Plumpton, C.6
  • 102
    • 0028931949 scopus 로고
    • Regional and maturation-associated expression of endothelin 2 in rat gastrointestinal tract
    • de la Monte SM, Quertermous T, Hong CC, Bloch KD, (1995). Regional and maturation-associated expression of endothelin 2 in rat gastrointestinal tract. J Histochem Cytochem 43: 203-209.
    • (1995) J Histochem Cytochem , vol.43 , pp. 203-209
    • De La Monte, S.M.1    Quertermous, T.2    Hong, C.C.3    Bloch, K.D.4
  • 103
    • 0026690522 scopus 로고
    • Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b
    • Morton AJ, Davenport AP, (1992). Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b. Brain Res 581: 299-306.
    • (1992) Brain Res , vol.581 , pp. 299-306
    • Morton, A.J.1    Davenport, A.P.2
  • 104
    • 0027958721 scopus 로고
    • Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors
    • Nambi P, Pullen M, Spielman W, (1994). Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors. J Pharmacol Exp Ther 268: 202-207.
    • (1994) J Pharmacol Exp Ther , vol.268 , pp. 202-207
    • Nambi, P.1    Pullen, M.2    Spielman, W.3
  • 105
    • 84867581900 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic properties of SOL1: A novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme
    • Nelissen J, Lemkens P, Sann H, Bindl M, Bassissi F, Jasserand D, et al. (2012). Pharmacokinetic and pharmacodynamic properties of SOL1: a novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme. Life Sci 91: 587-592.
    • (2012) Life Sci , vol.91 , pp. 587-592
    • Nelissen, J.1    Lemkens, P.2    Sann, H.3    Bindl, M.4    Bassissi, F.5    Jasserand, D.6
  • 106
    • 84865428817 scopus 로고    scopus 로고
    • Pathophysiological roles of endothelin receptors in cardiovascular diseases
    • Ohkita M, Tawa M, Kitada K, Matsumura Y, (2012). Pathophysiological roles of endothelin receptors in cardiovascular diseases. J Pharmacol Sci 119: 302-313.
    • (2012) J Pharmacol Sci , vol.119 , pp. 302-313
    • Ohkita, M.1    Tawa, M.2    Kitada, K.3    Matsumura, Y.4
  • 108
    • 84874302223 scopus 로고    scopus 로고
    • Endothelin-converting enzymes degrade intracellular beta-amyloid produced within the endosomal/lysosomal pathway and autophagosomes
    • Pacheco-Quinto J, Eckman EA, (2013). Endothelin-converting enzymes degrade intracellular beta-amyloid produced within the endosomal/lysosomal pathway and autophagosomes. J Biol Chem 288: 5606-5615.
    • (2013) J Biol Chem , vol.288 , pp. 5606-5615
    • Pacheco-Quinto, J.1    Eckman, E.A.2
  • 109
    • 33751544162 scopus 로고    scopus 로고
    • A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation in mice
    • Palanisamy GS, Cheon YP, Kim J, Kannan A, Li Q, Sato M, et al. (2006). A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation in mice. Mol Endocrinol 20: 2784-2795.
    • (2006) Mol Endocrinol , vol.20 , pp. 2784-2795
    • Palanisamy, G.S.1    Cheon, Y.P.2    Kim, J.3    Kannan, A.4    Li, Q.5    Sato, M.6
  • 110
    • 62849094138 scopus 로고    scopus 로고
    • Endothelin receptor antagonists: Status and learning 20 years on
    • Palmer MJ, (2009). Endothelin receptor antagonists: status and learning 20 years on. Prog Med Chem 47: 203-237.
    • (2009) Prog Med Chem , vol.47 , pp. 203-237
    • Palmer, M.J.1
  • 111
    • 84882597884 scopus 로고    scopus 로고
    • Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: A randomised, crossover, double-blind, placebo-controlled trial
    • Parvanova A, van der Meer IM, Iliev I, Perna A, Gaspari F, Trevisan R, et al. (2013). Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 1: 19-27.
    • (2013) Lancet Diabetes Endocrinol , vol.1 , pp. 19-27
    • Parvanova, A.1    Van Der Meer, I.M.2    Iliev, I.3    Perna, A.4    Gaspari, F.5    Trevisan, R.6
  • 112
    • 84893041865 scopus 로고    scopus 로고
    • Macitentan: First global approval
    • Patel T, McKeage K, (2014). Macitentan: first global approval. Drugs 74: 127-133.
    • (2014) Drugs , vol.74 , pp. 127-133
    • Patel, T.1    McKeage, K.2
  • 113
    • 84891791940 scopus 로고    scopus 로고
    • The IUPHAR/BPS Guide to PHARMACOLOGY: An expert-driven knowledgebase of drug targets and their ligands
    • DATABASE ISSUE
    • Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al. (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res 42 (Database Issue): D1098-D1106.
    • (2014) Nucleic Acids Res , vol.42 , pp. D1098-D1106
    • Pawson, A.J.1    Sharman, J.L.2    Benson, H.E.3    Faccenda, E.4    Alexander, S.P.5    Buneman, O.P.6
  • 114
    • 84867582084 scopus 로고    scopus 로고
    • New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus
    • Pernow J, Shemyakin A, Böhm F, (2012). New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus. Life Sci 91: 507-516.
    • (2012) Life Sci , vol.91 , pp. 507-516
    • Pernow, J.1    Shemyakin, A.2    Böhm, F.3
  • 115
    • 0028868580 scopus 로고
    • Delineation of endothelin receptors in human left ventricular smooth-muscle cells
    • Peter MG, Davenport AP, (1995). Delineation of endothelin receptors in human left ventricular smooth-muscle cells. J Cardiovasc Pharmacol 26 (Suppl. 3): S355-S357.
    • (1995) J Cardiovasc Pharmacol , vol.26 , pp. S355-S357
    • Peter, M.G.1    Davenport, A.P.2
  • 116
    • 0030020431 scopus 로고    scopus 로고
    • Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart
    • Peter MG, Davenport AP, (1996). Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Br J Pharmacol 117: 455-462.
    • (1996) Br J Pharmacol , vol.117 , pp. 455-462
    • Peter, M.G.1    Davenport, A.P.2
  • 117
    • 0032967302 scopus 로고    scopus 로고
    • Blockade and reversal of endothelin-induced constriction in pial arteries from human brain
    • Pierre LN, Davenport AP, (1999). Blockade and reversal of endothelin-induced constriction in pial arteries from human brain. Stroke 30: 638-643.
    • (1999) Stroke , vol.30 , pp. 638-643
    • Pierre, L.N.1    Davenport, A.P.2
  • 118
    • 0029813755 scopus 로고    scopus 로고
    • The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044
    • Plumpton C, Ferro CJ, Haynes WG, Webb DJ, Davenport AP, (1996a). The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br J Pharmacol 119: 311-314.
    • (1996) Br J Pharmacol , vol.119 , pp. 311-314
    • Plumpton, C.1    Ferro, C.J.2    Haynes, W.G.3    Webb, D.J.4    Davenport, A.P.5
  • 120
    • 84862817809 scopus 로고    scopus 로고
    • Place your BETs: The therapeutic potential of bromodomains
    • Prinjha RK, Witherington J, Lee K, (2012). Place your BETs: the therapeutic potential of bromodomains. Trends Pharmacol Sci 33: 146-153.
    • (2012) Trends Pharmacol Sci , vol.33 , pp. 146-153
    • Prinjha, R.K.1    Witherington, J.2    Lee, K.3
  • 122
    • 33744899835 scopus 로고    scopus 로고
    • B receptor agonist, IRL-1620, on paclitaxel plasma pharmacokinetics of breast tumor rats
    • B receptor agonist, IRL-1620, on paclitaxel plasma pharmacokinetics of breast tumor rats. Exp Biol Med 231: 1120-1122.
    • (2006) Exp Biol Med , vol.231 , pp. 1120-1122
    • Rai, A.1    Rajeshkumar, N.V.2    Gulati, A.3
  • 123
    • 84918819375 scopus 로고    scopus 로고
    • Endothelin B receptor agonist, IRL 1620, a novel adjuvant to enhance the delivery and efficacy of paclitaxel in a rat mammary tumor model
    • Rajeshkumar NV, Rai A, Gulati A, (2005a). Endothelin B receptor agonist, IRL 1620, a novel adjuvant to enhance the delivery and efficacy of paclitaxel in a rat mammary tumor model. Clin Cancer Res 11: 9138S-9239S.
    • (2005) Clin Cancer Res , vol.11 , pp. 9138S-9239S
    • Rajeshkumar, N.V.1    Rai, A.2    Gulati, A.3
  • 124
    • 27944449731 scopus 로고    scopus 로고
    • Endothelin B receptor agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats
    • Rajeshkumar NV, Rai A, Gulati A, (2005b). Endothelin B receptor agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats. Breast Cancer Res Treat 94: 237-247.
    • (2005) Breast Cancer Res Treat , vol.94 , pp. 237-247
    • Rajeshkumar, N.V.1    Rai, A.2    Gulati, A.3
  • 125
    • 84885047361 scopus 로고    scopus 로고
    • Endothelin-2 signaling in the neural retina promotes the endothelial tip cell state and inhibits angiogenesis
    • Rattner A, Yu H, Williams J, Smallwood PM, Nathans J, (2013). Endothelin-2 signaling in the neural retina promotes the endothelial tip cell state and inhibits angiogenesis. Proc Natl Acad Sci U S A 110: E3830-E3839.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , pp. E3830-E3839
    • Rattner, A.1    Yu, H.2    Williams, J.3    Smallwood, P.M.4    Nathans, J.5
  • 128
    • 62449145673 scopus 로고    scopus 로고
    • β-Arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis
    • Rosanò L, Cianfrocca R, Masi S, Spinella F, Di Castro V, Biroccio A, et al. (2009). β-Arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci U S A 106: 2806-2811.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 2806-2811
    • Rosanò, L.1    Cianfrocca, R.2    Masi, S.3    Spinella, F.4    Di Castro, V.5    Biroccio, A.6
  • 129
    • 84886100276 scopus 로고    scopus 로고
    • β-Arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced beta-catenin signaling
    • Rosanò L, Cianfrocca R, Tocci P, Spinella F, Di Castro V, Spadaro F, et al. (2013a). β-Arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced beta-catenin signaling. Oncogene 32: 5066-5077.
    • (2013) Oncogene , vol.32 , pp. 5066-5077
    • Rosanò, L.1    Cianfrocca, R.2    Tocci, P.3    Spinella, F.4    Di Castro, V.5    Spadaro, F.6
  • 130
    • 84883153220 scopus 로고    scopus 로고
    • Endothelin 1 in cancer: Biological implications and therapeutic opportunities
    • Rosanò L, Spinella F, Bagnato A, (2013b). Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 13: 637-651.
    • (2013) Nat Rev Cancer , vol.13 , pp. 637-651
    • Rosanò, L.1    Spinella, F.2    Bagnato, A.3
  • 131
    • 84867578454 scopus 로고    scopus 로고
    • Endothelin receptor antagonists for the treatment of pulmonary artery hypertension
    • Rubin LJ, (2012). Endothelin receptor antagonists for the treatment of pulmonary artery hypertension. Life Sci 91: 517-521.
    • (2012) Life Sci , vol.91 , pp. 517-521
    • Rubin, L.J.1
  • 132
    • 0037149718 scopus 로고    scopus 로고
    • Bosentan therapy for pulmonary arterial hypertension
    • Rubin LJ, Badesch DB, Barst RJ, et al. (2002). Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346: 896-903.
    • (2002) N Engl J Med , vol.346 , pp. 896-903
    • Rubin, L.J.1    Badesch, D.B.2    Barst, R.J.3
  • 133
    • 0029858496 scopus 로고    scopus 로고
    • Characterization of the binding of endothelin ETB selective ligands in human and rat heart
    • Russell FD, Davenport AP, (1996). Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Br J Pharmacol 119: 631-636.
    • (1996) Br J Pharmacol , vol.119 , pp. 631-636
    • Russell, F.D.1    Davenport, A.P.2
  • 134
    • 0033617232 scopus 로고    scopus 로고
    • Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells
    • Russell FD, Davenport AP, (1999a). Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells. Circ Res 84: 891-896.
    • (1999) Circ Res , vol.84 , pp. 891-896
    • Russell, F.D.1    Davenport, A.P.2
  • 135
    • 0032940038 scopus 로고    scopus 로고
    • Secretory pathways in endothelin synthesis
    • Russell FD, Davenport AP, (1999b). Secretory pathways in endothelin synthesis. Br J Pharmacol 26: 391-398.
    • (1999) Br J Pharmacol , vol.26 , pp. 391-398
    • Russell, F.D.1    Davenport, A.P.2
  • 136
    • 0032504759 scopus 로고    scopus 로고
    • Human endothelial cell storage granules: A novel intracellular site for isoforms of the endothelin-converting enzyme
    • Russell FD, Skepper JN, Davenport AP, (1998a). Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res 83: 314-321.
    • (1998) Circ Res , vol.83 , pp. 314-321
    • Russell, F.D.1    Skepper, J.N.2    Davenport, A.P.3
  • 137
    • 0031890934 scopus 로고    scopus 로고
    • Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin
    • Russell FD, Skepper JN, Davenport AP, (1998b). Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin. J Cardiovasc Pharmacol 31: 424-430.
    • (1998) J Cardiovasc Pharmacol , vol.31 , pp. 424-430
    • Russell, F.D.1    Skepper, J.N.2    Davenport, A.P.3
  • 138
    • 84867574271 scopus 로고    scopus 로고
    • Permissive role of endothelin receptors in tumor metastasis
    • Said N, Theodorescu D, (2012). Permissive role of endothelin receptors in tumor metastasis. Life Sci 91: 522-527.
    • (2012) Life Sci , vol.91 , pp. 522-527
    • Said, N.1    Theodorescu, D.2
  • 139
    • 0025605930 scopus 로고
    • Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
    • Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, et al. (1990). Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735.
    • (1990) Nature , vol.348 , pp. 732-735
    • Sakurai, T.1    Yanagisawa, M.2    Takuwa, Y.3    Miyazaki, H.4    Kimura, S.5    Goto, K.6
  • 140
    • 84867574381 scopus 로고    scopus 로고
    • The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans
    • Seed A, Kuc RE, Maguire JJ, Hillier C, Johnston F, Essers H, et al. (2012). The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans. Life Sci 91: 743-748.
    • (2012) Life Sci , vol.91 , pp. 743-748
    • Seed, A.1    Kuc, R.E.2    Maguire, J.J.3    Hillier, C.4    Johnston, F.5    Essers, H.6
  • 141
    • 42149140537 scopus 로고    scopus 로고
    • Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1
    • Seyrantepe V, Hinek A, Peng J, Fedjaev M, Ernest S, Kadota Y, et al. (2008). Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation 117: 1973-1981.
    • (2008) Circulation , vol.117 , pp. 1973-1981
    • Seyrantepe, V.1    Hinek, A.2    Peng, J.3    Fedjaev, M.4    Ernest, S.5    Kadota, Y.6
  • 142
    • 80051766443 scopus 로고    scopus 로고
    • Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage
    • Sharkovska Y, Kalk P, von Websky K, Relle K, Pfab T, Alter M, et al. (2011). Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage. Clin Lab 57: 507-515.
    • (2011) Clin Lab , vol.57 , pp. 507-515
    • Sharkovska, Y.1    Kalk, P.2    Von Websky, K.3    Relle, K.4    Pfab, T.5    Alter, M.6
  • 144
    • 84898645285 scopus 로고    scopus 로고
    • Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment
    • Sidharta PN, Lindegger N, Ulc I, Dingemanse J, (2013a). Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment. J Clin Pharmacol 55: 291-300.
    • (2013) J Clin Pharmacol , vol.55 , pp. 291-300
    • Sidharta, P.N.1    Lindegger, N.2    Ulc, I.3    Dingemanse, J.4
  • 145
    • 84898645285 scopus 로고    scopus 로고
    • Safety, tolerability, pharmacokinetics, and pharmacodynamics of macitentan, an endothelin receptor antagonist, in an ascending multiple-dose study in healthy subjects
    • Sidharta PN, van Giersbergen PL, Dingemanse J, (2013b). Safety, tolerability, pharmacokinetics, and pharmacodynamics of macitentan, an endothelin receptor antagonist, in an ascending multiple-dose study in healthy subjects. J Clin Pharmacol 54: 291-300.
    • (2013) J Clin Pharmacol , vol.54 , pp. 291-300
    • Sidharta, P.N.1    Van Giersbergen, P.L.2    Dingemanse, J.3
  • 146
    • 0025321142 scopus 로고
    • Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: Possible physiological significance
    • Skolovsky M, Galron R, Kloog Y, Bdolah A, Indig FE, Blumberg S, et al. (1990). Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc Natl Acad Sci U S A 87: 4702-4706.
    • (1990) Proc Natl Acad Sci U S A , vol.87 , pp. 4702-4706
    • Skolovsky, M.1    Galron, R.2    Kloog, Y.3    Bdolah, A.4    Indig, F.E.5    Blumberg, S.6
  • 147
    • 84878913517 scopus 로고    scopus 로고
    • Endothelin, kidney disease, and hypertension
    • Speed JS, Pollock DM, (2013). Endothelin, kidney disease, and hypertension. Hypertension 61: 1142-1145.
    • (2013) Hypertension , vol.61 , pp. 1142-1145
    • Speed, J.S.1    Pollock, D.M.2
  • 148
    • 0023946168 scopus 로고
    • Sarafotoxins S6: Several isotoxins from Atractaspis engaddensis (burrowing asp) venom that affect the heart
    • Takasaki C, Tamiya N, Bdolah A, Wollberg Z, Kochva E, (1988). Sarafotoxins S6: several isotoxins from Atractaspis engaddensis (burrowing asp) venom that affect the heart. Toxicon 26: 543-548.
    • (1988) Toxicon , vol.26 , pp. 543-548
    • Takasaki, C.1    Tamiya, N.2    Bdolah, A.3    Wollberg, Z.4    Kochva, E.5
  • 149
    • 0026764085 scopus 로고
    • A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor
    • Takai M, Umemura I, Yamasaki K, Watakabe T, Fujitani Y, Oda K, et al. (1992). A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor. Biochem Biophys Res Commun 184: 953-959.
    • (1992) Biochem Biophys Res Commun , vol.184 , pp. 953-959
    • Takai, M.1    Umemura, I.2    Yamasaki, K.3    Watakabe, T.4    Fujitani, Y.5    Oda, K.6
  • 151
    • 11144267307 scopus 로고    scopus 로고
    • Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats
    • Thone-Reinke C, Simon K, Richter CM, Godes M, Neumayer HH, Thormahlen D, et al. (2004). Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats. J Cardiovasc Pharmacol 44: S76-S79.
    • (2004) J Cardiovasc Pharmacol , vol.44 , pp. S76-S79
    • Thone-Reinke, C.1    Simon, K.2    Richter, C.M.3    Godes, M.4    Neumayer, H.H.5    Thormahlen, D.6
  • 152
    • 0030032386 scopus 로고    scopus 로고
    • Molecular pharmacology of endothelin converting enzymes
    • Turner AJ, Murphy LJ, (1996). Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 26: 91-102.
    • (1996) Biochem Pharmacol , vol.26 , pp. 91-102
    • Turner, A.J.1    Murphy, L.J.2
  • 153
    • 0030899822 scopus 로고    scopus 로고
    • Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX
    • Turner AJ, Tanzawa K, (1997). Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 11: 355-364.
    • (1997) FASEB J , vol.11 , pp. 355-364
    • Turner, A.J.1    Tanzawa, K.2
  • 154
    • 0035112440 scopus 로고    scopus 로고
    • The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function
    • Turner AJ, Isaac RE, Coates D, (2001). The neprilysin (NEP). family of zinc metalloendopeptidases: genomics and function. Bioessays 23: 261-269.
    • (2001) Bioessays , vol.23 , pp. 261-269
    • Turner, A.J.1    Isaac, R.E.2    Coates, D.3
  • 155
    • 34247847802 scopus 로고    scopus 로고
    • Ambrisentan, a non-peptide endothelin receptor antagonist
    • Vatter H, Seifert V, (2006). Ambrisentan, a non-peptide endothelin receptor antagonist. Cardiovasc Drug Rev 24: 63-76.
    • (2006) Cardiovasc Drug Rev , vol.24 , pp. 63-76
    • Vatter, H.1    Seifert, V.2
  • 156
    • 84867574237 scopus 로고    scopus 로고
    • Endothelin and endothelin receptors in the renal and cardiovascular systems
    • Vignon-Zellweger N, Heiden S, Miyauchi T, Emoto N, (2012). Endothelin and endothelin receptors in the renal and cardiovascular systems. Life Sci 91: 490-500.
    • (2012) Life Sci , vol.91 , pp. 490-500
    • Vignon-Zellweger, N.1    Heiden, S.2    Miyauchi, T.3    Emoto, N.4
  • 157
  • 158
    • 0029065161 scopus 로고
    • Endogenous endothelin generation maintains vascular tone in humans
    • Webb DJ, (1995). Endogenous endothelin generation maintains vascular tone in humans. J Hum Hypertens 9: 459-463.
    • (1995) J Hum Hypertens , vol.9 , pp. 459-463
    • Webb, D.J.1
  • 159
    • 84873713624 scopus 로고    scopus 로고
    • Interaction profile of macitentan, a new non-selective endothelin-1 receptor antagonist, in vitro
    • Weiss J, Theile D, Ruppell MA, Speck T, Spalwisz A, Haefeli WE, (2013). Interaction profile of macitentan, a new non-selective endothelin-1 receptor antagonist, in vitro. Eur J Pharmacol 701: 168-175.
    • (2013) Eur J Pharmacol , vol.701 , pp. 168-175
    • Weiss, J.1    Theile, D.2    Ruppell, M.A.3    Speck, T.4    Spalwisz, A.5    Haefeli, W.E.6
  • 160
    • 84871583767 scopus 로고    scopus 로고
    • Early progress in epigenetic regulation of endothelin pathway genes
    • Welch AK, Jacobs ME, Wingo CS, Cain BD, (2013). Early progress in epigenetic regulation of endothelin pathway genes. Br J Pharmacol 168: 327-334.
    • (2013) Br J Pharmacol , vol.168 , pp. 327-334
    • Welch, A.K.1    Jacobs, M.E.2    Wingo, C.S.3    Cain, B.D.4
  • 161
    • 79951893913 scopus 로고    scopus 로고
    • Novel therapy approach in primary stroke prevention: Simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously hypertensive, stroke-prone rats improves survival
    • Wengenmayer C, Krikov M, Mueller S, Lucht K, Villringer A, Hocher B, et al. (2011). Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously hypertensive, stroke-prone rats improves survival. Neurol Res 33: 201-207.
    • (2011) Neurol Res , vol.33 , pp. 201-207
    • Wengenmayer, C.1    Krikov, M.2    Mueller, S.3    Lucht, K.4    Villringer, A.5    Hocher, B.6
  • 163
    • 0027992642 scopus 로고
    • ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1
    • Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, et al. (1994). ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473-485.
    • (1994) Cell , vol.78 , pp. 473-485
    • Xu, D.1    Emoto, N.2    Giaid, A.3    Slaughter, C.4    Kaw, S.5    Dewit, D.6
  • 164
    • 84873607949 scopus 로고    scopus 로고
    • Epigenetics of hypoxic pulmonary arterial hypertension following intrauterine growth retardation rat: Epigenetics in PAH following IUGR
    • Xu XF, Lv Y, Gu WZ, Tang LL, Wei JK, Zhang LY, et al. (2013). Epigenetics of hypoxic pulmonary arterial hypertension following intrauterine growth retardation rat: epigenetics in PAH following IUGR. Respir Res 14: 20.
    • (2013) Respir Res , vol.14 , pp. 20
    • Xu, X.F.1    Lv, Y.2    Gu, W.Z.3    Tang, L.L.4    Wei, J.K.5    Zhang, L.Y.6
  • 165
    • 0031940499 scopus 로고    scopus 로고
    • Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene
    • Yanagisawa H, Yanagisawa M, Kapur RP, Richardson JA, Williams SC, Clouthier DE, et al. (1998). Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125: 825-836.
    • (1998) Development , vol.125 , pp. 825-836
    • Yanagisawa, H.1    Yanagisawa, M.2    Kapur, R.P.3    Richardson, J.A.4    Williams, S.C.5    Clouthier, D.E.6
  • 166
    • 0034086055 scopus 로고    scopus 로고
    • Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development
    • Yanagisawa H, Hammer RE, Richardson JA, Emoto N, Williams SC, Takeda SI, et al. (2000). Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest 105: 1373-1382.
    • (2000) J Clin Invest , vol.105 , pp. 1373-1382
    • Yanagisawa, H.1    Hammer, R.E.2    Richardson, J.A.3    Emoto, N.4    Williams, S.C.5    Takeda, S.I.6
  • 167
    • 0012576401 scopus 로고
    • Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide
    • Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, et al. (1988). Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A 85: 6964-6967.
    • (1988) Proc Natl Acad Sci U S A , vol.85 , pp. 6964-6967
    • Yanagisawa, M.1    Inoue, A.2    Ishikawa, T.3    Kasuya, Y.4    Kimura, S.5    Kumagaye, S.6
  • 168
    • 0033983604 scopus 로고    scopus 로고
    • Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi
    • Yap EY, Battistini B, McKay KO, (2000). Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi. Br J Pharmacol 129: 170-176.
    • (2000) Br J Pharmacol , vol.129 , pp. 170-176
    • Yap, E.Y.1    Battistini, B.2    McKay, K.O.3
  • 169
    • 84918791522 scopus 로고    scopus 로고
    • Characterisation of the 'endothelin-like domain peptide' (ELDP) co-synthesised with endothelin-1 from the EDN1 gene
    • Yuzgulen J, Wood EG, Villar IC, Douthwaite JA, Patel NSA, Jegard J, et al. (2013). Characterisation of the 'endothelin-like domain peptide' (ELDP) co-synthesised with endothelin-1 from the EDN1 gene. Life Sciences 93: DOI: 10.1016/j.lfs.2013.12.037.
    • (2013) Life Sciences , vol.93
    • Yuzgulen, J.1    Wood, E.G.2    Villar, I.C.3    Douthwaite, J.A.4    Patel, N.S.A.5    Jegard, J.6
  • 170
    • 0033609028 scopus 로고    scopus 로고
    • Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure
    • Zolk O, Quattek J, Sitzler G, Schrader T, Nickenig G, Schnabel P, et al. (1999). Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation 99: 2118-2123.
    • (1999) Circulation , vol.99 , pp. 2118-2123
    • Zolk, O.1    Quattek, J.2    Sitzler, G.3    Schrader, T.4    Nickenig, G.5    Schnabel, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.